Literature DB >> 26423119

Advancing Urinary Protein Biomarker Discovery by Data-Independent Acquisition on a Quadrupole-Orbitrap Mass Spectrometer.

Jan Muntel1, Yue Xuan2, Sebastian T Berger1, Lukas Reiter3, Richard Bachur4, Alex Kentsis5, Hanno Steen1.   

Abstract

The promises of data-independent acquisition (DIA) strategies are a comprehensive and reproducible digital qualitative and quantitative record of the proteins present in a sample. We developed a fast and robust DIA method for comprehensive mapping of the urinary proteome that enables large scale urine proteomics studies. Compared to a data-dependent acquisition (DDA) experiments, our DIA assay doubled the number of identified peptides and proteins per sample at half the coefficients of variation observed for DDA data (DIA = ∼8%; DDA = ∼16%). We also tested different spectral libraries and their effects on overall protein and peptide identifications and their reproducibilities, which provided clear evidence that sample type-specific spectral libraries are preferred for reliable data analysis. To show applicability for biomarker discovery experiments, we analyzed a sample set of 87 urine samples from children seen in the emergency department with abdominal pain. The whole set was analyzed with high proteome coverage (∼1300 proteins/sample) in less than 4 days. The data set revealed excellent biomarker candidates for ovarian cyst and urinary tract infection. The improved throughput and quantitative performance of our optimized DIA workflow allow for the efficient simultaneous discovery and verification of biomarker candidates without the requirement for an early bias toward selected proteins.

Entities:  

Keywords:  DIA; QE; biomarker discovery; spectral library; urine proteomics

Mesh:

Substances:

Year:  2015        PMID: 26423119      PMCID: PMC4993212          DOI: 10.1021/acs.jproteome.5b00826

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  38 in total

1.  Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest.

Authors:  C S Spahr; M T Davis; M D McGinley; J H Robinson; E J Bures; J Beierle; J Mort; P L Courchesne; K Chen; R C Wahl; W Yu; R Luethy; S D Patterson
Journal:  Proteomics       Date:  2001-01       Impact factor: 3.984

Review 2.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

3.  More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS.

Authors:  Annette Michalski; Juergen Cox; Matthias Mann
Journal:  J Proteome Res       Date:  2011-02-28       Impact factor: 4.466

4.  Bioanalytical high-throughput selected reaction monitoring-LC/MS determination of selected estrogen receptor modulators in human plasma: 2000 samples/day.

Authors:  J Zweigenbaum; J Henion
Journal:  Anal Chem       Date:  2000-06-01       Impact factor: 6.986

5.  Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics.

Authors:  Ruth Hüttenhain; Martin Soste; Nathalie Selevsek; Hannes Röst; Atul Sethi; Christine Carapito; Terry Farrah; Eric W Deutsch; Ulrike Kusebauch; Robert L Moritz; Emma Niméus-Malmström; Oliver Rinner; Ruedi Aebersold
Journal:  Sci Transl Med       Date:  2012-07-11       Impact factor: 17.956

6.  An exclusion list based label-free proteome quantification approach using an LTQ Orbitrap.

Authors:  Jan Muntel; Michael Hecker; Dörte Becher
Journal:  Rapid Commun Mass Spectrom       Date:  2012-03-30       Impact factor: 2.419

7.  Urinary proteomic biomarkers in coronary artery disease.

Authors:  Lukas U Zimmerli; Eric Schiffer; Petra Zürbig; David M Good; Markus Kellmann; Laetitia Mouls; Andrew R Pitt; Joshua J Coon; Roland E Schmieder; Karlheinz H Peter; Harald Mischak; Walter Kolch; Christian Delles; Anna F Dominiczak
Journal:  Mol Cell Proteomics       Date:  2007-10-19       Impact factor: 5.911

8.  Using iRT, a normalized retention time for more targeted measurement of peptides.

Authors:  Claudia Escher; Lukas Reiter; Brendan MacLean; Reto Ossola; Franz Herzog; John Chilton; Michael J MacCoss; Oliver Rinner
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984

9.  Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues.

Authors:  Roland Bruderer; Oliver M Bernhardt; Tejas Gandhi; Saša M Miladinović; Lin-Yang Cheng; Simon Messner; Tobias Ehrenberger; Vito Zanotelli; Yulia Butscheid; Claudia Escher; Olga Vitek; Oliver Rinner; Lukas Reiter
Journal:  Mol Cell Proteomics       Date:  2015-02-27       Impact factor: 5.911

10.  New markers: urine xanthine oxidase and myeloperoxidase in the early detection of urinary tract infection.

Authors:  Pınar Ciragil; Ergul Belge Kurutas; Meral Miraloglu
Journal:  Dis Markers       Date:  2014-01-29       Impact factor: 3.434

View more
  39 in total

1.  Quantitative Mass Spectrometry-Based Proteomics: An Overview.

Authors:  Svitlana Rozanova; Katalin Barkovits; Miroslav Nikolov; Carla Schmidt; Henning Urlaub; Katrin Marcus
Journal:  Methods Mol Biol       Date:  2021

2.  PIQED: automated identification and quantification of protein modifications from DIA-MS data.

Authors:  Jesse G Meyer; Sushanth Mukkamalla; Hanno Steen; Alexey I Nesvizhskii; Bradford W Gibson; Birgit Schilling
Journal:  Nat Methods       Date:  2017-06-29       Impact factor: 28.547

3.  SWATH Mass Spectrometry Performance Using Extended Peptide MS/MS Assay Libraries.

Authors:  Jemma X Wu; Xiaomin Song; Dana Pascovici; Thiri Zaw; Natasha Care; Christoph Krisp; Mark P Molloy
Journal:  Mol Cell Proteomics       Date:  2016-05-09       Impact factor: 5.911

Review 4.  Current state of the art for enhancing urine biomarker discovery.

Authors:  Michael Harpole; Justin Davis; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2016-06       Impact factor: 3.940

5.  Quantitative proteomic characterization of human sperm cryopreservation: using data-independent acquisition mass spectrometry.

Authors:  Longlong Fu; Qi An; Kaishu Zhang; Ying Liu; Yue Tong; Jianfeng Xu; Fang Zhou; Xiaowei Wang; Ying Guo; Wenhong Lu; Xiaowei Liang; Yiqun Gu
Journal:  BMC Urol       Date:  2019-12-16       Impact factor: 2.264

6.  Impact of the Identification Strategy on the Reproducibility of the DDA and DIA Results.

Authors:  Carolina Fernández-Costa; Salvador Martínez-Bartolomé; Daniel B McClatchy; Anthony J Saviola; Nam-Kyung Yu; John R Yates
Journal:  J Proteome Res       Date:  2020-06-19       Impact factor: 4.466

Review 7.  Towards comprehensive and quantitative proteomics for diagnosis and therapy of human disease.

Authors:  Paolo Cifani; Alex Kentsis
Journal:  Proteomics       Date:  2016-12-21       Impact factor: 3.984

8.  Deep Proteomics Using Two Dimensional Data Independent Acquisition Mass Spectrometry.

Authors:  Kyung-Cho Cho; David J Clark; Michael Schnaubelt; Guo Ci Teo; Felipe da Veiga Leprevost; William Bocik; Emily S Boja; Tara Hiltke; Alexey I Nesvizhskii; Hui Zhang
Journal:  Anal Chem       Date:  2020-02-26       Impact factor: 6.986

Review 9.  Clinical applications of quantitative proteomics using targeted and untargeted data-independent acquisition techniques.

Authors:  Jesse G Meyer; Birgit Schilling
Journal:  Expert Rev Proteomics       Date:  2017-05       Impact factor: 3.940

10.  Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer.

Authors:  Melissa A Hoffman; Bin Fang; Eric B Haura; Uwe Rix; John M Koomen
Journal:  J Proteome Res       Date:  2017-11-22       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.